Accordingly, there has been a lot of interest in whether an increased level of CISD2 can protect the brain from Aβ-mediated toxicity, reducing neuronal damage in the hippocampus, thereby improving the AD phenotype by attenuating AD pathogenesis within the brain. This evidence concerns the gene CISD2 and Alzheimer disease.